Experience with the Avalon bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO

S. Speggiorin, S. G. Robinson, C. Harvey, C. Westrope, G. M. Faulkner, P. Kirkland, Giles J. Peek

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: We report a single centre experience of neonatal respiratory ECMO using the Avalon double-lumen venous cannula and compare it with reports in the literature. Results: Between 2008 and 2012, the Avalon cannula was used in 72 neonates: median age at cannulation was 1.8 days (IQR 1.2-2.8 days) and bodyweight 3.4 Kg (3.0-3.7 Kg). Meconium aspiration syndrome (61.1%), persistent hypertension of the newborn (25%) and congenital diaphragmatic hernia (5.6%) were the most common diagnoses. Complications occurred in 19 patients (26.4%): cannula site bleeding in 6 (8.3%), the cannula perforating the right atrial wall and requiring emergency midline sternotomy in 5 (6.9%) and the cannula needing repositioning in 3 (4.2%). Overall survival at discharge or transfer to the referring hospital was 88.8%. Successful wean off ECMO occurred in 68 patients (94.4%) after a median of 90.5 hours (63.4 -136.11). ECMO support was withdrawn in 4 patients (5.6%). Conclusions: The Avalon dual-lumen veno-venous cannula can be used for respiratory ECMO in the neonatal population. However, as the incidence of right atrial perforation is not negligible, we suspended its used in this group of patients.

Original languageEnglish (US)
Pages (from-to)250-254
Number of pages5
JournalPerfusion
Volume30
Issue number3
DOIs
StatePublished - Apr 19 2015
Externally publishedYes

Fingerprint

Perforating
hypertension
incidence
experience
Group
Meconium Aspiration Syndrome
Newborn Infant
Sternotomy
Catheterization
literature
Cannula
Emergencies
Hemorrhage
Hypertension
Survival
Incidence
Population

Keywords

  • cannula complication
  • complication
  • ECMO
  • neonate
  • respiratory failure

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Safety Research
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

Speggiorin, S., Robinson, S. G., Harvey, C., Westrope, C., Faulkner, G. M., Kirkland, P., & Peek, G. J. (2015). Experience with the Avalon bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO. Perfusion, 30(3), 250-254. https://doi.org/10.1177/0267659114540020

Experience with the Avalon bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO. / Speggiorin, S.; Robinson, S. G.; Harvey, C.; Westrope, C.; Faulkner, G. M.; Kirkland, P.; Peek, Giles J.

In: Perfusion, Vol. 30, No. 3, 19.04.2015, p. 250-254.

Research output: Contribution to journalArticle

Speggiorin, S, Robinson, SG, Harvey, C, Westrope, C, Faulkner, GM, Kirkland, P & Peek, GJ 2015, 'Experience with the Avalon bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO', Perfusion, vol. 30, no. 3, pp. 250-254. https://doi.org/10.1177/0267659114540020
Speggiorin S, Robinson SG, Harvey C, Westrope C, Faulkner GM, Kirkland P et al. Experience with the Avalon bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO. Perfusion. 2015 Apr 19;30(3):250-254. https://doi.org/10.1177/0267659114540020
Speggiorin, S. ; Robinson, S. G. ; Harvey, C. ; Westrope, C. ; Faulkner, G. M. ; Kirkland, P. ; Peek, Giles J. / Experience with the Avalon bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO. In: Perfusion. 2015 ; Vol. 30, No. 3. pp. 250-254.
@article{980bb60a4b2e4653b0ace97970e415ef,
title = "Experience with the Avalon bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO",
abstract = "Objective: We report a single centre experience of neonatal respiratory ECMO using the Avalon double-lumen venous cannula and compare it with reports in the literature. Results: Between 2008 and 2012, the Avalon cannula was used in 72 neonates: median age at cannulation was 1.8 days (IQR 1.2-2.8 days) and bodyweight 3.4 Kg (3.0-3.7 Kg). Meconium aspiration syndrome (61.1{\%}), persistent hypertension of the newborn (25{\%}) and congenital diaphragmatic hernia (5.6{\%}) were the most common diagnoses. Complications occurred in 19 patients (26.4{\%}): cannula site bleeding in 6 (8.3{\%}), the cannula perforating the right atrial wall and requiring emergency midline sternotomy in 5 (6.9{\%}) and the cannula needing repositioning in 3 (4.2{\%}). Overall survival at discharge or transfer to the referring hospital was 88.8{\%}. Successful wean off ECMO occurred in 68 patients (94.4{\%}) after a median of 90.5 hours (63.4 -136.11). ECMO support was withdrawn in 4 patients (5.6{\%}). Conclusions: The Avalon dual-lumen veno-venous cannula can be used for respiratory ECMO in the neonatal population. However, as the incidence of right atrial perforation is not negligible, we suspended its used in this group of patients.",
keywords = "cannula complication, complication, ECMO, neonate, respiratory failure",
author = "S. Speggiorin and Robinson, {S. G.} and C. Harvey and C. Westrope and Faulkner, {G. M.} and P. Kirkland and Peek, {Giles J.}",
year = "2015",
month = "4",
day = "19",
doi = "10.1177/0267659114540020",
language = "English (US)",
volume = "30",
pages = "250--254",
journal = "Perfusion",
issn = "0267-6591",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Experience with the Avalon bicaval double-lumen veno-venous cannula for neonatal respiratory ECMO

AU - Speggiorin, S.

AU - Robinson, S. G.

AU - Harvey, C.

AU - Westrope, C.

AU - Faulkner, G. M.

AU - Kirkland, P.

AU - Peek, Giles J.

PY - 2015/4/19

Y1 - 2015/4/19

N2 - Objective: We report a single centre experience of neonatal respiratory ECMO using the Avalon double-lumen venous cannula and compare it with reports in the literature. Results: Between 2008 and 2012, the Avalon cannula was used in 72 neonates: median age at cannulation was 1.8 days (IQR 1.2-2.8 days) and bodyweight 3.4 Kg (3.0-3.7 Kg). Meconium aspiration syndrome (61.1%), persistent hypertension of the newborn (25%) and congenital diaphragmatic hernia (5.6%) were the most common diagnoses. Complications occurred in 19 patients (26.4%): cannula site bleeding in 6 (8.3%), the cannula perforating the right atrial wall and requiring emergency midline sternotomy in 5 (6.9%) and the cannula needing repositioning in 3 (4.2%). Overall survival at discharge or transfer to the referring hospital was 88.8%. Successful wean off ECMO occurred in 68 patients (94.4%) after a median of 90.5 hours (63.4 -136.11). ECMO support was withdrawn in 4 patients (5.6%). Conclusions: The Avalon dual-lumen veno-venous cannula can be used for respiratory ECMO in the neonatal population. However, as the incidence of right atrial perforation is not negligible, we suspended its used in this group of patients.

AB - Objective: We report a single centre experience of neonatal respiratory ECMO using the Avalon double-lumen venous cannula and compare it with reports in the literature. Results: Between 2008 and 2012, the Avalon cannula was used in 72 neonates: median age at cannulation was 1.8 days (IQR 1.2-2.8 days) and bodyweight 3.4 Kg (3.0-3.7 Kg). Meconium aspiration syndrome (61.1%), persistent hypertension of the newborn (25%) and congenital diaphragmatic hernia (5.6%) were the most common diagnoses. Complications occurred in 19 patients (26.4%): cannula site bleeding in 6 (8.3%), the cannula perforating the right atrial wall and requiring emergency midline sternotomy in 5 (6.9%) and the cannula needing repositioning in 3 (4.2%). Overall survival at discharge or transfer to the referring hospital was 88.8%. Successful wean off ECMO occurred in 68 patients (94.4%) after a median of 90.5 hours (63.4 -136.11). ECMO support was withdrawn in 4 patients (5.6%). Conclusions: The Avalon dual-lumen veno-venous cannula can be used for respiratory ECMO in the neonatal population. However, as the incidence of right atrial perforation is not negligible, we suspended its used in this group of patients.

KW - cannula complication

KW - complication

KW - ECMO

KW - neonate

KW - respiratory failure

UR - http://www.scopus.com/inward/record.url?scp=84924980678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924980678&partnerID=8YFLogxK

U2 - 10.1177/0267659114540020

DO - 10.1177/0267659114540020

M3 - Article

C2 - 24972812

AN - SCOPUS:84924980678

VL - 30

SP - 250

EP - 254

JO - Perfusion

JF - Perfusion

SN - 0267-6591

IS - 3

ER -